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ABSTRACT 
DNA double helix has considerable conformational 
flexibility. It is a dynamic structure in which different 
conformations are in equilibrium with each other. The 
concept of structural flexibility in DNA was sharply 
illustrated by the discovery of left handed Z-DNA. Both 
right handed B-DNA and left handed Z-DNA are double helical 
conformations with antiparallel chains that are held 
together by Watson-Crick hydrogen bonding between the bages. 
All the nucleotides along the B-DNA have the same 
conformation. However, the nucleotides along the left 
handed double helix alternate in syn and anti conformations. 
An equilibrium exists between B-DNA and Z-DNA. 
Double stranded calf thymus DNA was brominated in 
high salt concentration. Conformational change in DNA was 
detected by various techniques like UV absorption spectra, 
thermal denaturation studies and Si nuclease sensitivity. 
Characteristic property of Z-DNA viz. red shift in UV 
spectra and hyperchromacity at 295 nm was observed in 
brominated DNA indicates that the polymer had adopted Z- or 
Z-like conformation. 
Thermal denaturation data as well indicates that 
brominated DNA is thermodynamically less stable than its 
correspondingly unmodified polymer. The electrophoretic 
mobility of brominated DNA (Br-DNA) was increased as 
compared to native DNA (nDNA) indicates the generation of 
some single stranded portions reiterating that the molecule 
undergo B -> Z or Z- like conformation as a result of 
bromination in high salt concentration. After nuclease Si 
treatment of Br-DNA, the band shifted its position to lower 
side which indicates that these portions are digested on the 
treatment with Si nuclease. 
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In brominated nDNA, cytosine and guanine were 
modified to the extent of 20.8% and 39.2% respectively, 
which suggests that guanine is a better substrate for 
bromination as compared to cytosine. Similar results have 
also been reported in the case of typical Z-DNA (i.e. 
brominated poly(dG-dC).poly(dG-dC ) ) where after bromination 
35% of the guanine residues had reacted in the C8 position 
and 17% of the cytosine residues at C5 position. 
Antibodies were generated in experimental animals 
against Br-DNA. The immunogenecity and specificity of 
induced antibodies was probed against various nucleic acids 
antigens by direct binding ELISA and competition ELISA. On 
the basis of competition experiments the antibodies 
recognized only the modified form of the polymer i.e. Br-DNA 
and not the unmodified form. Anti-Br-DNA antibodies also 
recognized poly(dG-dm C).poly(dG-dm C) and Br-poly(dG-dC). 
poly(dG-dC). These polymers are known to exist in 
Z-conformation in solutions under physiological condition. 
No binding of anti-Br-DNA antibodies was observed with 
bases. The induced antibodies are thus conformational 
specific reacting only with the modified form of native DNA. 
Quantitative evaluation of antibody binding was 
ascertained by precipitin titration. Immune complex 
formation was also detected by gel retardation assay in 
\;hich retarded mobility of Br-DNA-anti-Br DNA antibody 
complex was seen as a further indication of antibody 
intraction. 
The importance of lysine residues on the binding 
characteristics of immune IgG \;as ascertained by trinitro-
phenylation of lysine residues. Results demonstrated a 
direct relationship betv/een the degree of lysine 
modification and antigen binding. 
Ill 
Antibodies specific for Z-DNA arise in certain 
autoimmune states and are found in both murine and human 
systemic lupus erythematosus. In the present study, various 
normal human sera and sera of patients with SLE were checked 
for the presence of antibodies against nDNA and Z-DNA. 
Anti-DNA autoantibodies were found to be specific for native 
double stranded DNA with poor reactivity with single 
stranded polymer. SLE anti-native antibodies also showed 
appreciable binding with brominated DNA. 
In conclusion, bromination of native calf thymus DNA 
in high salt concentration converts some portions of DNA 
from right handed conformations to left handed Z-
conformations. Modified polymer is highly immunogenic. The 
antibodies induced against brominated DNA appears to be 
highly specific for the modified polymer recognizing the 
changed conformations of the modified polymer. The altered 
polymer showed appreciable binding with human anti-DNA 
autoantibodies. The possibility of an altered polymer 
acting as antigen for the production of human auto-
antibodies could be one of the factors for the pathogenesis 
of SLE. 
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INTRODUCTION 
The immune system has tremendous diversity and the 
need between self and non-self has been recognized long ago. 
In the body, there is a complicated mechanism establish to 
distinguish self and non-self determinants (Bicker, 1986) so 
as to avoid the embarassment of autoreactivity. However, 
things all mechanisms have a risk of breakdown leading to 
self recognition. 
It is generally accepted that self reactive 
lymphocytes exist in the body. A situation occurs in which 
self reactive lymphocytes and autoantigens can make contact 
in the normal individual and therefore there must be 
controlling mechanisms which operate in normal circumstances 
to inhibit the triggering of the autoimmune reaction. It 
seems that suppressor cells are important in the containment 
of this autoreactivity. It has been postulated that defects 
in more than one type of T-suppressor may be important for 
the development of autoimmune response. 
Autoantibodies can be present in the sera of patients 
with or without autoimmune diseases. The defination of 
abnormality related to autoantibody levels in usually based 
on abnormal quality, rather than affinity or avidity. Thus 
abnormal autoantibody levels can result in clinical, 
subclinical or preclinical autoimmune condition (Albert and 
Norbert, 1988). The autoimmune states include a number of 
diseases in which antibody to nucleic acids or nucleic acid 
protein complexes are formed (Peter and Estes, 1972). The 
presence of spontaneously occurring circulating and tissue 
fixed autoantibodies to many nucleic acids are of prime 
importance in the pathogenesis of various autoimmune 
diseases which includes systemic lupus erythematosus (SLE), 
rheumatoid arthritis (RA), progressive systemic sclerosis 
(PSS), Sjogrens syndrome (SS), dermatomyosities (DM) and 
mixed connective tissue disease (MCTD). Autoantibodies, a 
characteristic feature of autoimmune disorders are also 
observed in patients with chronic liver diseases (Kurki et 
al, 1984; Gluud et al, 1983). However, it is not clear 
whether their presence is an expression of an autoimmune 
pathogenesis or an epiphenomenon reflecting a non-specific 
B-cell stimulation, which is known to occur in cirrhosis. 
Diseases like primary biliary cirrhosis (PBS) and chronic 
active hepatitis (CAH) commonly considered to be autoimmune 
disorders, are associated with highly specific autoanti-
bodies (anti-mitocondrial and anti-smooth muscle 
respectively). Autoantibodies found in alcoholic liver 
diseases (ALD) and cryptogenic cirrhosis (CC) on the other 
hand, are less specific favouring a non-specific expression 
(Komkoff et al, 1989). 
Of various autoimmune diseases, SLE is considered to 
be the prototype. Sera of patients with SLE contain a large 
variety of antibodies to intracellular proteins and nucleic 
acids (Table 1 ). A variety of organs and tissues are 
affected in SLE and patients show a range of disease 
manifestations and severity (Narendra and Hoffman, 1989). 
These organs include central nervous system (CNS). Between 
25 to 70% of the SLE patients have been reported to have CNS 
involvement (Carr et al, 1978). The neuropsychiatric 
symptoms of CNS-SLE are extremely diverse, ranging from 
organic brain syndrome to schizophreniform disorders (Baker 
et al, 1973; Tan et al, 1982). Antibodies reactive to CNS 
antigens have been demonstrated in human SLE sera and in 
cerebrospinal fluid (Wilson 1979; Golombek et al, 1986). 
Antibrain anibodies or immune complexes can induce change in 
chemistry and electrophysiology of the brain and in its 
behaviour (William et al, 1980; Hoffman et al, 1982). 
Immunological abnormalities, genetic factors, virus 
and environmental stimuli have been thought to contribute 
Table 1 
Cellular Antigens Reactive with SLE Sera. 
Antigenic specificy References 
Antibodies of Nucleic acids 
a) dsDNA 
b) ssDNA 
c) dsRNA 
d) ssRNA 
e) tRNA, ribosomal RNA, 
viral RNA 
f) Poly ADP-ribose 
g) Z-DNA 
Antibodies to Histones 
HI, H2A, H2B, H3 & H4 
Antobodies to non-histones 
proteins 
a) Sm antigen 
Antibodies to Other Nuclear 
Antigens 
a) SSB/La 
b) SSA/Ro 
Tan et al, 1966 
Stoller, 1986 
Koffler et al, 1971 
Winfield et al, 1974 
Rubin, et al, 1986a 
Tan et al, 1966 
Stoller, 1986 
Eilat et al, 1978 
Rubin et al, 1986 
Eilat et al, 1976 
Lamon & Bennet, 1970 
Arnott et al, 1974 
Sibley et al, 1984 
Fritzler et al, 1978 
Rubin et al, 1982 
Rubin et al, 1985 
Portanova et al, 1987 
Notman et al, 1975 
Conner et al, 1982 
Fisher et al, 1983 
M. Takei et al, 1987 
Reddy et al, 1983b 
Chan, et al, 1986, 1987 
Yamagata et al, 1984 
Harmon et al, 1984 
Lieu et al, 1984 
c) Ku 
d) Alu RNA-Protein 
e) Ribosomal RNP 
f) PCNA/Cyclin 
Francoeur et al, 1986 
Reeves et al, 1985 
Mimori et al, 1986 
Kole et al, 1985 
Elkon et al, 1985 
Francoeur et al, 1985 
Mathews et al, 1984a 
Takasaki et al, 1984 
Ogata et al, 1985 
Kurki et al, 1986 
Ogata et al, 1987 
the diverse clinical and serological feature of SLE. 
Attention has been focused on the anti-DNA antibodies 
because they appear to be most uniquely related with this 
disease and its period of clinical activity, especially with 
its renal manifestations. Exceptions have been reported 
however and questions have arisen as to the complete 
diagnostic specificity of anti-DNA assays, as well as their 
reliability as a guide to management of the disease. 
Evaluation of clinical correlations involving 
anti-DNA antibodies requires attention to several questions, 
including the characterization of the test antigen for 
purity and for its content of native or denatured DNA, the 
distinction between binding by antibodies and 
non-immunoglobulin proteins; and the quantification of 
antibody. In addition functional properties of antibodies, 
such as complement-fixing activity, functional affinity, 
immunoglobulin class and the tendency to bind bivalently to 
one antigen molecule are potentially important for the 
biological and clinical significance of the anti-DNA 
response. Familiarity with the reagents and procedures used 
in a particular laboratory are also very important. With 
well characterized reagents and assays, the anti-DNA 
measurements can be remarkably selective for SLE and very 
useful for monitoring and pridicting the disease activity. 
The study of anti-DNA antibodies has several 
motivations. One derives from the role of anti-DNA antibody 
formation as a part of an autoimmune response that is 
characteristic of SLE. By understanding the nature and 
origin of these antibodies and of their target sites, more 
specific control of the disease would be possible. A second 
motivation is the consideration of anti-DNA antibodies as 
model systems for protein recognition of nucleic acid 
components and conformations-systems in which adequate 
amounts of proteins with varying recognition sites can be 
used to analyze the intraction. Specific antibodies can 
also be used as biochemical reagents for detection of unique 
conformations that may constitute a small fraction of the 
total nucleic acid of complex biological systems. Their use 
as anticancer agents has also been proposed. In the realm 
of research, questions on the specificity and origin of 
anti-DNA antibodies touch on fundamental issue of 
autoimmunity and immune regulation. 
Induction of Antibodies to B-Helical Native DNA 
Most attempts to induce anti-native antibodies by 
immunization with purified native DNA have been unsuccessful, 
whether DNA was administered alone or in complexes with 
protein such as methylated bovine serum albumin (MBSA). 
Immunization of either MRL-lpr/lpr or C56B1/6 mice with 
native calf thymus DNA did not increase anti-native DNA 
antibody level above the level that resulted from injection 
of adjuvant alone (which does cause some increase) (Madaio 
et al, 1984). Injection of histone-DNA complexes yielded 
some anti-histone but not anti-DNA antibodies (Stollar and 
Ward, 1970) nor did immunization with isolated nuclesomes 
induce anti-DNA antibodies (Einck et al, 1982). A 
monoclonal antibody from animals immunized with poly 
(dT-dC).Poly(dG-dA), a duplex DNA gave a weak cross reaction 
with native calf DNA (Lee et al, 1985). A monoclonal IgM 
antibody selective for native DNA was obtained from a mouse 
that was immunized with DNA and several different synthetic 
DNA analogues (Huang et al, 1985). It is not clear which of 
the immunizing stimuli was important in the selection of 
this antibody, or whether it represented the autoantibody 
formation. Antibodies to deoxyribonucleotide-protein 
conjugates induced in rabbits or rats were specific for 
denatured DNA. 
Adjuvants (probably lipopolysachharide component) can 
expand a population of cells that produce anti-DNA 
autoantibodies. So it is important to carry out control 
experiments with adjuvants alone alongside immunization with 
nucleic acids. A similar background was also seen in 
induced antibodies to a B-helical native DNA polymer, 
poly (dT-dG) .poly(dC-dA) by _in vitro immunization (Weiner 
et al, 1987). 
SLE Anti-DNA Antibodies and Antigenic Structure of DNA 
Nucleic acids are not immunogenic by themselves unlike 
proteins and carbohydrates. Nucleic acid reactive antibodies 
are present in the sera of human beings and animals affected 
with certain autoimmune diseases. 
Anti-DNA antibodies are usually classified as 
anti-denatured (single stranded) or anti-native (double 
stranded) DNA. Anti-DNA antibodies appear to be more 
specific for SLE and reflect more closely the clinical 
status of the patient. The different specificities can be 
understood to a large extent in terms of structural 
determinants in DNA. 
DNA can present several kinds of antigenic sites for 
correspondingly heterogenous SLE sera. Purine or pyrimidine 
bases or base sequences upto a length of five or six serve 
as determinants for SLE antibodies that react only with 
denatured DNA (Stollar, 1973). In native helical DNA, the 
bases are inaccessibly directed inward, they are exposed to 
antibody only iiL- structure is disrupted by heat or by 
chemical denaturants. Correspondingly base specific 
antibodies do not bind native DNA and their binding of 
denatured DNA is not inhibited by native DNA. Precise 
specificity in terms of which base or base sequence is 
preferred, varies from serum to serum. 
A second type of antibody in SLE serum does react with 
native DNA probably with the deoxyribose-phosphate backbone. 
These antibodies may also recognize helical regions in 
denatured DNA. To distinguish this type from base specific 
antibodies, it is important to be sure that fully base 
paired helical DNA is used as a test antigen. Closed circular 
bacteriophage DNA (Aarden et al, 1975), synthetic 
poly(dAT).poly(dAT) (Steinman et al, 1976) or intracellular 
circular DNA (Aarden et al, 1975) can be used as fully 
helical structures. 
Other subpopulations of anti-DNA antibodies may also 
occur. They may recognize the backbone of one strand and 
may be able to react with both native and denatured DNA. 
Some antibodies may react with synthetic and single stranded 
homopolydeoxyribonucleotides such as poly(dT) or poly(dC). 
Some of them may be base specific, others may react with the 
backbone and thus with several polynucleotides (Koffler 
et al, 1971). 
The size of DNA also influence some assays. A single 
antigen combining site is large enough to encompass both 
backbones of native DNA over an extent of only two or three 
base pairs and in the case of denatured DNA determinants, a 
sequence of five or six nucleotides (Stollar, 1973, 1975). 
When helical fragments of native DNA were tested in a 
compititive binding assay, pieces of 40 to 50 base pairs 
were required for significant binding by several sera. This 
may reflect a minimal size requirement for maintenance of a 
particular stable conformation or a marked increase in 
affinity when bivalent binding becomes possible (Papalian 
et al, 1980; Ali et al, 1985). Larger fragments were still 
more efficient and the use of very high molecular weight DNA 
is required for optimal sensitivity of anti-DNA assays 
(Geisert et al, 1975; Aarden et al, 1976). Closed circular 
bacteriophage DMA can also be used both to ensure the native 
structure and to provide an antigen of uniform size and 
molecular weight. The precise specificity and extent of 
heterogeneity is difficult to assess with whole SLE sera. A 
recent approach to these problems is the examination of 
monoclonal hybridoma antibodies from autoimmune mice. 
Monoclonal Autoantibodies: Specificity and Cross Reactivity 
Another approach to study anti-DNA autoantibodies has 
been the preparation of murine or human hybridomas or 
transformed cell lines. The anti-DNA monoclonal 
autoantibodies were derived from either NZB/NZW (Hahn et al, 
1980) or MRL-lpr/lpr (Andrzejewski et al, 1980) mice. 
Without immunization, spleen cells or peripheral blood cells 
from mice or humans with autoimmune disease have been fused 
with corresponding mouse myeloma or human lymphoblastoid 
cells to obtain hybridomas. The hybridomas were screened 
for the production of anti-DNA antibodies. Many monoclonal 
antibodies have been isolated and their specificities tested 
with a variety of synthetic and natural nucleic acids. The 
murine monoclonal hybridomas produce mainly IgG but also IgM 
or IgA autoantibodies. Most of them bind with denatured 
DNA, but some bind nDNA (Tron et al, 1982; Kubota et al, 
1986). Human monoclonal autoantibodies, from either 
hybridomas (Cairns et al, 1984) or EBV-transformed cells 
(Sasaki et al, 1984) are nearly all IgM molecules that react 
with denatured DNA. Approximetely 2 to 5 percent, human 
myeloma proteins, both IgM and IgG bind to denatured or 
native DNA. 
Diverse nature of autoantibody response can be 
understand with homogenous monoclonal antibodies. Many 
monoclonal antibodies cross react with several synthetic 
polynucleotides (Andrzejewski et al, 1981; Kardost et al, 
10 
1982) so that the universe of antibodies is smaller than 
what would be required to provide a distinct specificity for 
each form of nucleic acid. Immunization with synthetic 
polynucleotide usually leads to a specific antibody that does 
not show this degree of cross reactivity. Also poly(dT), or 
poly(dG) or poly(dl) acts as preferred reactants for both 
murine and human hybridomas products even through these are 
polyribonucleotides. They are complex polymers that can 
exist as single or multistranded structures (Arnott et al, 
1974) and could provide a variety of conformations in which 
base and/or backbone may be available to antibody. The 
sugar conformation of these polymers and therefore the 
phosphate group spacing can resemble the B-form conformation 
of DNA rather than the A-form conformation of RNA. The 
antipoly(dT) and antipoly(l) reactivities are not mutually 
exclusive and the classification of antibodies by 
specificity leads to overlapping groups with no completely 
distinct boundries. 
Monoclonal antibodies has been tested for specificity 
with various poly, oligo and mononucleotides as inhibitors 
of DNA binding. A general finding has been that antibodies 
selected for DNA binding have not bound to single or double 
stranded RNA (Lee et al, 1982; Seeman et al, 1965). However, 
a single monoclonal antibody may react with poly(I), 
poly(dT), native and denatured DNA and Z-DNA (Shoenfeld et 
al, 1983). In such cases, it seems unlikely that the 
specificity is determined mainly by purine or pyrimidine 
base. These antibodies may recognize an accessible feature 
of the sugar phosphate and that there is a requirement for a 
specific spacing of the phosphate groups for a antibody 
combining site. 
Some anti-DNA autoantibodies cross react even with 
structures that are not nucleic acid like phospholipids 
(Lafer et al, 1981; Koike et al, 1982). It may be 
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rationalized on the basis of presentation of phosphate 
groups on the polar head groups of the phospholipids that 
may be analogous to the phosphates of the DNA backbone. 
This may be the basis for the binding of some of the 
antibodies to bacterial cell surface structures (Carroll 
et al, 1985) and for the "lupus anticoagulant" activity of 
certain of the anti-DNA antibodies (Lafer et al, 1981). 
Anti-DNA antibodies in SLE sera can be inhibited by 
cardiolipin (Koike et al, 1982). Additional cardiolipin 
reactivity antibodies that do not recognize DNA are also 
present in SLE serum. 
Antibodies to Right Handed Helical Polynucleotides 
Although native DNA itself has not been immunogenic in 
this form, many helical structures that differ from this 
form can be effective immunogens. Nearly all the antibodies 
that are formed recognize only the differences betv/een the 
immunogen and native DNA as they do not react with naturally 
occuring native B-DNA. Antibodies to A-helical forms such 
as double stranded RNA or RNA-DNA hybrids have shown high 
selectivity for either of these forms of helix and have 
served as reagents for the identification of the 
corresponding dsRNA helixes in virus infected cells (Stollar 
and Stollar, 1970; Ng et al, 1983) or of annealed RNA-DNA 
hybrid in polytene chromosomes of Drosophila (Rudkin and 
Stollar, 1977; Alcover et al, 1982). Antibodies of high 
selectivity have been induced by right handed helical forms 
of polydeoxyribonucleotides. Poly(dG).poly(dC) induce 
highly specific antibody (Stollar, 1970). Poly(dG-dC) and 
poly(dG-dA).poly(dT-dC) induced weak responses on 
immunization of rabbits with methylated bovine serum albumin 
complex (Zarling et al, 1984; Madaio et al, 1984). 
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Triple helical nucleic acids have also induced 
specific antibodies. Antibodies induced by triple stranded 
polyribonucleotide poly(A).poly(U).poly(I) can be separated 
into subpopulaions that are specific for three different 
aspects of the triple helix (Rainen and Stollar, 1977). 
Triple helical nucleic acids may be involved in viral 
replication, gene regulation, bacterial transcription and 
chromosome structure. These antibodies are important in 
recognition of triple helical structures in naturally 
occuring nucleic acids as well as in providing a model for 
specific protein-nucleic acid intraction. 
Structural Features of Z-DNA 
The double helical DNA has considerable conformational 
flexibility. It is not a static molecule but rather a 
dynamic structure in which different conform.ations are in 
equilibrium with each other. The discovery of Z-DNA has 
added yet another complexity in the conformation of native 
DNA. 
The Z-DNA structure has many conformational features 
that distinguish it from B-DNA. Both right handed DNA and 
left handed Z-DNA are double helical conformations with 
antiparallel chains that are held together by Watson-Crick 
hydrogen bonding between the bases. All the nucleotides 
along B-DNA have the same conformation. However, 
nucleotides along the left handed double helix alternate in 
syn and anti conformation of the bases. Since the syn 
conformation is more stable for purines than for 
pyrimidines, Z-DNA is favoured in nucleotide sequences that 
have alternations of purines and pyrimidines. In contrast 
to right handed B-DNA, Z-DNA has one deep helical groove 
that is formally analogous to the minor groove of B-DNA. 
The concave major groove of B-DNA forms the convex outer 
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surface of Z-DNA. In Z-DNA, asymetric unit is a 
dinucleotide compared to the mononucleotide found in B-DNA. 
The zigzag organization of the phosphates is a direct 
consequence of the two different conformations found in the 
nucleotide of Z-DNA. 
In B-DNA, there are typically J^.5 J3a_se pairs per 
helical turn, a helical pitch of 34°A and a diameter, of 
near 20°A. Z-DNA has 12 base pa^ irs per helical turn, a 
pitch of 44.6°A and a diameter of approximately 18°A. Thus, 
Z-DNA is somewhat slimmer than B-DNA and has a larger number 
of base pair per helical turn. 
Base pairs have also different relationship to the 
sugarphosphate chains. In converting a section of B-DNA to 
Z-DNA the base pairs must flip so that they are now upside 
down_ relative to the orientation that they had in B-DNA. 
This is brought about by rotating the purine residue about 
its glycosyl bond from anti to syn. In the case of 
pyrimidines, both the bases as well as sugar rotate about, 
produces zigzag backbone conformation of Z-DNA. 
Furthermore, there is a considerable change in the 
relationship of the bases to the sugar phosphate backbone in 
comparing the two molecules. The imidazole ring of guanine 
is found prominently on the outer part of the Z-DNA molecule 
with considerable exposure of guanine N7 and C8. These 
aizoms are shielded in B-DNA. This difference in 
accessibility explains the differences in the chemical 
reactivity of the two molecules. 
Purine residues can form syn conformations easily but 
are less common for pyrimidines (Davis, 1978). In Z-DNA the 
organization of base pairs is such that every other residue 
along the chain is in syn conformation. This implies that 
Z-DNA is more likely to be found is sequences that have 
alternations of purine and pyrimidines so that purines can 
exist in syn conformations. 
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The Z-DNA has been visualized in crystal structures 
containing 4 to 8 base pairs and the molecules have 
crystallized in orthorhombic and hexagonal lattices (Wang 
et al, 1979; Drew et atl, 1980; Wang et al, 1983; Wang 
et al, 1984). The sequences involved guanine cytosine as 
well as adenine-thymine base pairs. Some crystal structures 
have modifications such as cytosine residues v/ith methyl 
groups on the 5 position (Fugii et al, 1982). A self 
complementry Z-DNA structure with the sequence d(CpGpTpApCpG) 
has been solved in which the cytosine residues have either 
methyl or bromine atoms attached to C5 position (Wang et al, 
1984). The geometry of A-T base pair in Z-DNA is similar to 
that of the C-G base pairs with the adenine residues in the 
syn conformation. The water molecule in the helical groove 
of Z-DNA are disordered near the A-T base pairs in contrast 
to the high level of order found in the solvent of the 
segments containing C-G base pairs. The ordering is largely 
due to the presence of amino group on the 2 position of 
guanine, which hydrogen bonds to a water molecule and helps 
to organize others in the groove. Its absence in the A-T 
base pair is associated with the solvent disordering. For 
this reason, A-T base pairs forms Z-DNA less readily than 
C-G. 
Z-DNA crystal structure are no longer confined to 
alternations of purines and pyrimidines. A Z-DNA structure 
has been solved recently with the sequence d(CGATCG) in 
which cytosine residues are brominated on C5. The crystal 
is stabilized in the Z-conformation through the use of a 
Co(NH^) cation. Fiber diffraction studies have been 
carried out by Arnott and others (Arnott et al, 1980; Arnott 
et al, 1983 (a); Arnot et al, 1983 (b))on poly(dG-dC) which 
revealed that it could form the Z-DNA conformation. These 
studies suggested that B- to Z-DNA conversion could take 
place in the fiber itself. The conversion depends upon 
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relative humadity (Mahendraingam et al, 1983) and solvent 
composition (Sasisekharan and Brahmachari, 1981). 
Methods for Detecting Z-DNA 
In solution, there is equilibrium between right handed 
B-DNA and left handed Z-DNA. The actual distribution 
between these two states is strongly influenced by 
environmental conditions as well as by the sequence of 
nucleotides in the double helix. A variety of methods have 
been developed for detecting and measuring Z-DNA and differ-
entiate it from B-DNA as listed in Table 2. 
Use of Specific Anti-Z-DNA Antibodies 
Since Z-DNA was first detected in solution with 
poly(dG-dC) and since this polymer forms Z-DNA readily, most 
of the methods use this polymer in describing the modified 
properties. 
Synthetic poly(dG-dC) is stable as Z-DNA in 4 M NaCl 
and to stablize it in low-salt solution, chemical 
bromination was done. The bromine reacted largely with the 
C8 position of guanine and to a lesser extent with the C5 
position of cytosine. The bromine atom at C8 sterically 
prevents guanine from adopting the anti-conformation (Bugg 
and Thewalt 1969; Tavele and Sobell, 1970). When salt is 
dialyzed away from brominated poly(dG-dC), it remains as 
Z-DNA. Z-DNA is a strong immunogen (Lafer et al, 1981). 
The organisms probably becomes tolerant to B-DNA during the 
early stages of embryonic development but Z-DNA is not seen 
by the cells of immune system during early embryogenesis. 
When DNA is released from the cells that have broken down, 
nuclease cleavage probably converts any Z-DNA to B-DNA. The 
antibodies have high degree of specificity against Z-DNA and 
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Table 2. Physical and Chemical methods for detecting Z-DNA. 
Method 
Circular dichroism 
(UV and vaccum UV) 
X-ray crystallography 
3. UV absorbance changes 
4. Raman spectroscopy 
5. -^^ P NMR 
6. H NMR 
7. Hydrogen-deutrium exchange 
8. Gel Electrophoresis 
(one and two dimensional) 
9. Sedimentation 
10. Nitrocellulose filteration 
11. Light scattering 
12. Nuclease sensitivity 
13. Binding of chiral molecules 
14. Anti-Z-DNA antibody 
binding 
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do not intract with B-DNA or any other DNA or RNA poly or 
oligonucleotide. 
Monoclonal antibodies have also been produced against 
Z-DNA (Moller et al, 1982; Pohl, 1983; Thomae et al, 1983). 
They combine with different parts of the surface of Z-DNA. 
Some antibodies bind to the base pairs on the surface of 
molecule while others react with sugars and negative charged 
phosphate groups. These differences are uncovered by 
studing the reactivity of monoclonal antibodies with a 
variety of chemically modified polynucleotides that can form 
Z-DNA. Polyclonal and some monoclonal antibodies against 
Z-DNA can combine with Z-DNA even in the presence of high 
concentrations of NaCl (Lafer et al, 1983; Nordheim et al, 
1981). This property is very useful as it allows to v;ork 
with polymers as well as plasmids in different salt 
concentration. Varying salt concentration can be used to 
control the degree of Z-DNA formation and the specificity 
and reactivity of antibodies can be measured. The choice of 
Z-DNA modification can influence both the immunogenecity and 
the specificity of antibodies produced by it. 
By indirect immunofluorescence on Drosophila polytene 
chromosomes one can detect Z-DNA. Anti-Z-DNA antibodies 
raised in rabbit is added to a fixed cytological chromosome 
preparation. This is followed by the addition of a second 
goat antibody raised against rabbit antibody which has a 
fluorescent chromophore conjugated to it. This is 
visualized by illuminating the preparation at a wavelength 
that exicites fluorescence. Photographs are taken at the 
emitting wavelength so the position of the initial 
antibodies can be seen. 
Another method for using the antibody involves the 
retention of DNA on nitrocellulose filters. Naked DNA 
molecules can pass through the pores in filters while 
protein DNA complexes are retained on the filter. Nordheim 
et al, in 1982 used retention on nitrocellulose filters to 
detect the presence of Z-DNA when anti Z-DNA antibodies are 
present in the solution. The DNA is then digested with 
restricion endonucleases and the digest is passed through a 
nitrocellulose filter. The filterate contains all of the 
fragments that are not attached to the antibody while those 
bound to the antibody are retained on the nitrocellulose 
filter. By this method, one can identify specific sequences 
that are Z-DNA forming by using a variety of restriction 
endonucleases. 
Antibody bound to Z-DNA can also be visualized in 
electron microscope. Antibody visualization can be carried 
out by shadowing or through the use of ferritin coupled to 
the antibody (DiCapua et al, 1983; Miller et al, 1983; Lang 
et al, 1982; Stockton et al, 1983). This makes it possible 
to identify particular regions of a genome or of plasmids 
that form Z-DNA by measuring the position at which antibody 
molecules are found. 
Antibodies attached to columns covalently are also 
used as a method for separating plasmids that contain Z-DNA 
from those that do not contain Z-DNA (Thomae et al, 1983). 
This is a valuable method for identifying the occurence of 
Z-DNA in genomic libraries so that particular sequence can 
be isolated. 
Physical-Chemical Studies of Z-DNA 
Ultravoilet circular dichroism and measurement of 
absorbance at different wavelengths are easy methods to 
detect the formation of Z-DNA in polymers. Double stranded 
poly(dG-dC) in high salt concentration produces a near 
inversion of ultravoilet (UV) circular dichroism spectrum. 
In a low salt concentration, there is positive band at 280 nm 
and it is converted to a more intense negative band with a 
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minimum at 290 nm in 4 M NaCl (Pohl et al, 1972; Ramstein et 
al, 1980; Behe et al, 1981; Greve et al, 1981; Ivanow et al, 
1981; Ramstein et al, 1980). Similarly there is inversion 
of the negative band at 253 nm to a positive band at 265 nm. 
In high salt solution poly(dG-dC).poly(dG-dC) shows a 
decrease in absorbance at 260 nm and an increase at 295 nm 
compared to low salt spectrum. Although the effect is 
small, it is useful index for Z~DNA formation. 
In addition to these methods there are various other 
methods like Raman spectra and nuclear magnetic resonance 
(NMR). Raman spectrum measures the different types of 
vibrations of the components of macromolecules including 
bond stretching and bending. Some of these vibrations are 
sensitive to conformational change. Raman spectrum of a 
molecule is independent of whether it is fixed in a crystal 
lattice or tumbling free in solution. It is powerful tool 
for identifying a molecule in two different physical state. 
Nuclear magnetic resonance (NMR) spectroscopy provides 
a powerful method for studying the conformation of molecules 
in solution. 
Electron microscopy (EM) studies have also been 
carried out on Z-DNA. Z-DNA formation is frequently 
associated with extensive self association (Castleman and 
Erlanger, 1983). Self association can take place in an 
ordered manner giving rise to toroidal or rope-like 
structures. 
Chemical Factors Influencing the Equilibrium Between B and 
Z-DNA 
All the sequences of DNA have an equilibrium between 
right handed B-DNA and left handed Z-DNA. The position of 
that equilibrium is determined by the sequence of 
nucleotides and alternations of purines and pyrimidines 
favour the Z-DNA conformation, especially CG sequences. 
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In equilibrium, B-DNA has lower energy as compared to 
Z-DNA and Z-DNA can become the lower energy state only when 
the system is perturbed in some way to stabilize it. The 
relative instability of Z-DNA relative to B-DNA is partly 
associated with the fact that the phosphate groups on 
opposite strands come closer together in Z-DNA than in 
B-DNA. In Z-DNA, the distance of phosphate groups across the 
groove is 7.7°A compared to 11.7°A in B-DNA. High 
concentration of salt reduces the phosphate-phosphte 
repulsion (Pohl and Jovin, 1972). There are many factors 
that stabilize Z-DNA or lower its energy so that equilibrium 
shifts in its favour. Some of them are given below. 
Covalent DNA Modification 
There are a number of modifications by which Z-DNA can 
be stabilized e.g. bromination of poly{dG-dC).poly(dG-dC) in 
4 M NaCl. Bromination largely occurs at C8 position of 
guanine and to a lesser extent on the C5 position of 
cytosine (Nordheim et al, 1981; Holier et al, 1984). 
Bromination of guanine at C8 stabilizes the syn conformation. 
After bromination of poly(dG-dC) in 4 M NaCl so that 35% of 
the guanine residues had reacted in the C8 position and 17% 
of the cytosine residues at C5, the molecules remained in 
the Z-DNA conformation even after the removal of salt. 
Z-DNA can also be stabilized by the substitution of iodine 
atom at 05 position of cytosine. The carcinogen, 
N-acetoxyaminofluorene also stabilizes Z-DNA conformation. 
It reacts v\rith guanine at C8 position. 
Platinum complexes like chlorodiethylenetriamine 
platinum (II) chloride also stabilizes Z-DNA (Malfoy et al, 
1981; ushay et al, 1982). They react with N7 of guanine and 
act through the electrostatic contribution of the positively 
charged cation. The carcinogen aflatoxin also reacts with 
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the N7 of guanine but it stabilizes the B-conformation and 
prevents its conversion to Z-DNA, when salt is added to 
solution. 
Methylation of DNA strongly favours the formation of 
Z-DNA. Methyl group reacts v/ith N7 of guanine and C5 of 
cytosine (Mollar et al, 1981). Methylation of N7 stabilizes 
the Z-DNA by electrostatic means similar to the concentrated 
NaCl solutions. Behe and Felsenfeld (1981) compared the B-Z 
equilibrium of poly(dG-dC) and poly(dG-dm C).Poly(dG-dC) 
2+ 
requires 0.7 M Mg and 50 mM NaCl for the conversion of 
B-DNA to Z-DNA while poly(dG-dm C) requires three times less 
magnesium for the conversion. Methylation of CG residues is 
associated with gene inactivation and subsequent removal of 
the methyl group is associated with gene activation (Nickol 
and Felsenfeld, 1983). Methylated poly(dG-dC) has also been 
used to study nucleosome formation. 
Ions, especially cations, strongly influence the B->Z 
equilibrium. These cations cluster arund the negatively 
charged phosphates and reduce phosphate-phosphate repulsive 
intractions. The monovalent cations, sodium, potassium and 
lithium influence this equilibrium. Ions with higher 
valencies like polyamines with charges of +3 or +4 are very 
effective (Wang et al, 1979; Behe and Felsenfeld, 1981; 
Russell et al, 1983). The cobalt hexamine stabilizes the 
Z-DNA form at millimolar concentrations. Anions also effect 
B-Z equilibrium. Sodium perchlorate stabilizes Z-DNA beyond 
the contribution of its cation. Sodium acetate also effect 
the equilibrium. Agents that change the dielectric constant 
of water have been also found to sabilize Z-DNA. This 
includes the alcohols, ethanol, methanol, ethylene glycol 
and trifluoroethane. Z-DNA is stabilized in 40% ethanol or 
60% trifluoroethane. Lowering the dielectric constant means 
that ionic intractions will be felt more strongly, thxs w.ll 
Tesult in a closer clustering of cations near the negative 
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charged phosphate groups. This result in an effective 
screening and reduction of the phosphate-phosphate electric 
repulsion. 
Small molecules like ethidium, daunomycin and 
adriamycin also influence the equilibrium between B and 
Z-DNA. Addition of ethidium to Z-DNA converts it to 
intercalated B-DNA, because the B-form is more flexible and 
is able to form an intercalated complex with ethidium. The 
antitumor agents like daunomycin and adriamycin facilitates 
the formation of B-DNA when added to poly(dG-dC) or 
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poly{dG-dM C) in the Z-form. Addition of molecules like 
netropsin and distamycin to Z-DNA reverses it to B-DNA. 
Negative supercoiling also stabilizes Z-DNA. 
Z-DNA and Transcriptional Enhancers 
Z-DNA forming sequences occur in the circular genome 
of the simian DNA tumour virus (SV 40). SV 40 DNA revealed 
three segments of eight base pairs of alternating purines 
and pyrimidines that represent three major sites that form 
Z-DNA (Nordheim et al, 1983). These DNA segments are part 
of the transcriptional enhancer element of the promoter 
region (Gruss et al, 1981; Khoury and Gruss, 1983). 
Enhancers are cis-acting components of eucaryotic promoters 
that stimulate transcription in a manner relatively 
independent of position and orientation. The hyper-
sensitive sites on either side of the Z-DNA forming 
regions has their positions determined in part by the 
presence of a Z-DNA binding protein. Hipskind et al, in 1983 
demonstrated in vitro transcription of two xenopus met-tRNA 
genes where Z-DNA acts as a negative effector of RNA 
polymerase III. 
In vitro, transcription was studied in an alcohol 
containing solution that stabilize Z-DNA formation in 
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poly(dG-dC). The aggregated Z-DNA formed in this solvent 
(termed Z*) was capable of acting as a substrate for RNA 
polymerase II. 
Formation of Z-DNA resulted in the termination at the 
B-Z junction (Slightom et al, 1980). In converting 
poly(dG-dC) to Z-DNA resulted in a marked decrease of 
transcriptional activity using E. coli RNA polymerase. This 
raises the possibility that Z-DNA formation iri vitro may 
result in aborting the activity of RNA polymerase and as 
such may have the potential of a regulatory system that is 
responsive to the level of negative supercoiling in the 
template DNA. 
Role of Z-DNA in Recombination 
Smithies and worker (Slightom et al, 1980) identified 
nearby segments of d(CA/GT}-p. in a characterization of human 
fetal 'r-globulin genes which might act to facilitate the 
recombinational gene conversion events that led to the 
expansion in the number of globulin genes. Plamids 
containing segments of d(CA/GT) formed Z-DNA quite readily 
at intermidiate superhelical densities (Haniford and 
Pulleyblank, 1983; Nordheim and Rich, 1983). Recent 
investigations on synapsis formation between homologous 
circular plamids as promoted by Rec 1 protein from Ustilago 
demonstrated the formation of left handed DNA in the region 
of the paranemic joint (Kmiec and Holloman, 1984). This 
leads to general question whether recombination is 
intrisically associated with generation of negative 
superhelical strain and consequently with Z-DNA formation. 
If that is the case, then correlations may be found between 
the formaton of Z-DNA and the recombinational efficiency of 
different segments of DNA. 
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Chromatin Structure 
Since left handed Z-DNA can represent unique 
recognition signals for specific DNA-protein intractions, it 
may participate in the organization of the nuclear chromatin 
structure of eucaryotic chromosomes. Z-DNA can form 
nucleosomes and B-DNA nucleosomes are able to convert into 
Z-DNA nucleosomes (Miller et al, 1983). Z-DNA formation 
plays a important role in nucleosome phasing i.e. the 
positioning of nucleosomes on DNA relative to some 
functional sequence and may be involved in the generation of 
the nucleosome gap in the SV 40 minichromosomes (Scott and 
Wigmore, 1978; Varshavsky et al, 1981). 
Z-DNA and Carcinogens 
The conformations of B and Z-DNA differ substantially 
and interesting effects are found among the class of 
carcinogens that react with DNA (Neidle, 1981). One of the 
principal targets of carcinogen attack is the guanine 
residue and it plays a major role in Z-DNA stabilization. 
The reactivity of B and Z-DNA differ from each other. The 
guanine N7 and C8 atoms are completely accessible in Z-DNA 
but are much less accessible in B-DNA. This is consistent 
with stabilizing the Z-conformation by N-acetoxyaminofluorine 
which reacts covalently with guanine C8 (Sage and Leng, 
1980; Sage and Lenge, 1981; Wells et al, 1982; Rio and Leng, 
1983). Methylating carcinogens that add methyl groups to 
guanine N7 also stabilize Z-DNA (Moller et al, 1981). 
Other substances like adriamycin and daunomycin are 
mutagens and carcinogens convert the Z-DNA form to B-DNA 
form. Some of carcinogenic effect of these agents involves 
interfering with or modifying the B-Z equilibrium. If a 
regulatory region that undergo B to Z (or Z- to B) 
conversion is restrained by these compounds, could this 
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possible the inheritable defect that we recognize oncogenic 
conversion ? The answer is not yet known. 
Other suggestive roles 
Since Z-DNA formation is dependent upon alternations 
of purines and pyrimidines, the occurence of these segments 
in genomic DNA, is of interest. In the 5'-flanking 
sequences of yeast genes, frequent stretches of alternating 
purine and pyrimidines region are found. Such examples 
include the genes for alcohol dehydrogenase 1 and cytochrome 
C (Smith et al, 1979). Similar sequences are found in the 
promoter regions of other eucaryotic genes which indicates 
the possibility that they play a regulatory role. Such 
regulatory roles may be either positive or negative in 
nature depending on the site where it occurs. 
The Relationship of Z-DNA to Autoantibodies Formation 
Left-handed Z-DNA was considered to be strong 
immunogen. Both SLE sera (Lafer et al, 1983) and rheumatoid 
arthritis sera (Sibley et al, 1984) as well as monoclonal 
antibodies (Shoenfeld et al, 1983; Bergen et al, 1987) do 
react with brominated poly(dG-dC), a Z-helical DNA. The 
monoclonal antibody reactions are mainly cross-reactions by 
antibodies that also react with native/or denatured DNA and 
other polynucleotides (Shoenfeld et al, 1983), although some 
with greater selectivity for Z-DNA have been identified. 
Similarly, the serum antibodies include populations that are 
cross reactive and can be removed by absorption v/ith 
denatured DNA and others that react with Z-DNA and not v/ith 
native or denatured DNA. Still the latter differ from 
antibodies induced by delibrate immunization with Z-DNA, the 
SLE antibodies are much more sensitive to ionic strength and 
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do not react at 1 M NaCl, whereas the induced antibodies 
react well at 4 M NaCl. 
The findings that SLE sera react with Z-DNA led to 
suggestions that Z-DNA could be an immunizing stimulus for 
the formation of anti-DNA antibodies in this disease. The 
DNA present in immune complexes in SLE sera contain 
fragments of human DNA (Sano and Morimoto, 1981) and the 
(G+C) content of these fragments (50-60 percent) in higher 
than that of average human DNA (about 42 percent) (Sano and 
Morimoto, 1982; Van Helden, 1985). Drugs that induce 
antinuclear antibody formation can also favour Z-DNA 
formation (Thomas and Messner, 1986). 
Objectives of the Present Study 
The present work describes the bromination of purified 
calf thymus DNA under high salt concentration. The datje7^__^ 
points out the presence of Z-forming region(s) in native 
DNA. Antibodies have been raised in ^oat against the 
brominated polymer. The specificity and cross reactivity of 
induced antibodies have been investigated by compitition 
ELISA and other techniques. These antibodies were found to 
be specific for modified conformation. Br-DNA also showed 
high binding with human anti-DNA autoantibodies. The 
possibility of altered conformation of nDNA as immunogen for 
the production of human autoantibodies cross reactive with 
native DNA might be one of the consistic factors for the ^ 
pathogensis of SLE. 
EXPERIMENTAL 
A. Materials 
1. Chemicals 
Bovine serum albumin, methylated bovine serum albumin, 
anti-goat alkaline phosphatase conjugate, xylene cyanol FF, 
Coomassie Brilliant Blue R-250, poly D-lysine, calf thymus 
DNA, polydeoxyadenylate (Poly dA), polydeoxyctytidylate 
(poly dC), polyuradylate (Poly U), Freund's complete and 
incomplete adjuvants, Coomassie Brilliant Blue G 250 were 
purchased from Sigma Chemical Company, U.S.A. Polymers 
like poly(dA-dU).poly(dA-dU), poly(dl-dC).poly(dl-dC), 
poly(rG).poly(dG) were obtained from Pharmacia Fine 
Chemicals, Sweden. Tween-20, acrylamide, bisacrylamide, 
N-N-N'-N' tetraethylmethylene diamine and ammonium 
persulphate were obtained from Bio-Rad Laboratories, U.S.A. 
Polystyrene flat bottom microtiter ELISA plates having 96 
wells (7 mm in diameter) were obtained from Dynatech, U.S.A. 
A colorigenic substrate p-nitrophenyl phosphate was obtained 
from C.S.I.R. Center for Biochemicals, Delhi. Lysine was 
purchased from B.D.H. England. All other chemicals were of 
highest analytical grade available. 
2. Equipment 
Bausch and Lomb Spectronic - 20, Dynatech ELISA 
microplate reader MR-600, ELICO pH meter model Ll-IOT and 
Shimadzu UV-240 spectrophotometer equiped with a thermo-
programmer and controller were the major equipment used in 
this study. 
B. Methods 
1. Purification of calf thymus DNA ) . 
DNA solution (1-2 mg/ml) in 0.1 M SSC buffer (sodium 
citrate, sodium chloride, pH 7.3) was mixed with equal 
volume of chloroform and isoamyl alcohol mixture (24:1) in a 
stoppered container. The container was sealed properly and 
the contents mixed gently for one hour. The DNA containing 
aqueous phase was separated from organic layer and 
extraction was repeated once. Two volumes of ethanol was 
added to the DNA layer and was taken on a glass rod. The 
DNA was dissolved in 30 mM acetate buffer, pH 5.0 containing 
30 mM ZnCl~. The sample was treated with nuclease Si (250 
units/mg DNA) at 37°C for 30 minutes in order to get rid of 
single stranded portions. The reaction was stopped by the 
addition of one tenth volume of 0.2 M EDTA, pH 8.0. 
Extraction was repeated with chloroform-isoamyl alcohol and 
DNA was precipitated with cold ethanol. Purified DNA free 
of proteins and single stranded regions was dissolved in 
phosphate buffer saline. 
2. Determination of DNA concentration 
DNA was estimated colourimetrically according to 
Burton (1956) using diphenylamine reagent. 
a) Crystallization of diphenylamine 
Two gm of diphenylamine was dissolved in 100 gm of 
boiling hexane. Approximately 0.5 gm of activated charcol 
was added to the boiling mixture. The solution was filtered 
while hot and filterate kept at 4°C till the crystallization 
was complete. The crystals were separated by filteration 
and dried at room temperature. 
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b) Preparation of diphenylamine reagent 
Seven hundred fifty mg of crystallized diphenylamine 
was mixed with 50 ml glacial acetic acid and 0.75 ml of 
concentrated sulphuric acid. The reagent was prepared 
immediately before use. 
c) Procedure 
One ml of DNA solution v/as mixed with 1.0 ml of 1.0 N 
perchloric acid. The tubes were incubated at 70°C for 
15 minutes. Acetaldehyde (0.1 ml of 54.3 mM) was added, 
followed by 2.0 ml of diphenylamine reagent. The tubes were 
allowed to stand at room temperature for 16-20 hours and 
absorbance was recorded at 600 nm. The DNA concentration of 
unknown sample was determined from the standard plot 
(Fig. 1). 
3. Determination of protein concentration 
Protein was estimated by the methods of Lowry et al, 
(1951) and Bradford (1976). 
a) Estimation by Lowry's method 
The method involves the complexing of the protein 
+ 2 
with Cu in an alkaline solution. Copper catalyzes the 
reduction of tyrosine and tryptophan residues. The latter 
reaction leads to a blue colour which can be measured at 
660 nm. 
i) Folin-Ciocalten reagent 
The reagent was purchased from C.S.I.R. Center for 
Biochemicals, Delhi and diluted 1:4 with water before use. 
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ii) Alkaline copper reagent 
Fifty ml of 2 percent sodium carbonate solution 
prepared in 0.1 N sodium hydroxide was mixed with 0.5 ml of 
one percent copper sulphate and 0.5 ml of 2 percent sodium 
potassium tartrate. The reagent was prepared fresh before 
use. 
ill) Procedure 
One ml of protein sample was mixed with 5 ml of 
alkaline copper reagent. The tubes were left at room 
temperature for 10 minutes. One ml of diluted Folin's 
phenol reagent was added with immediate mixing and kept at 
room temperature for 30 minutes. The absorbance was read at 
660 nm. The protein content of unknown sample was 
determined from standard plot constricted by using bovine 
serum albumin. 
b) Dye-binding Assay 
Protein concentration was also determined according 
to Bradford (1976) . 
The method is based on the change in colour that 
occurs when Coomassie Brilliant Blue G-250 binds to protein 
in acidic solution. The protonated form of Coomassie Blue 
dye is a pale orange-red colour. The dye binds strongly to 
proteins, intracting both hydrophobically and at positively 
charged groups on the protein. In the environment of these 
positively charged groups, protonation is suppressed 
resulting in the formation of blue colour. 
i) Reagents 
a) Hundred gm of Coomassie Blue G-250 dye was dissolved in 
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50 ml of 95 percent double distilled ethanol and filtered to 
remove the undissolved material. 
b) Orthoposphoric acid (85%) was diluted to 1:5 
Solutions (a) and (b) were mixed in a 1:1 ratio just 
before use, forming the colour reagent. Solutions (a) and 
(b) are stable for months at room temperature. 
ii) Procedure 
Protein sample of appropriate dilutions were placed 
in test tubes and adjusted to a final volume of 0.1 ml with 
suitable buffer. Five ml of dye reagent was added and the 
tubes were thoroughly vortexed. The reaction was allowed to 
proceed at room temperature for 15 minutes and the 
absorbance recorded at 595 nm against a reagent blank. The 
colour is stable for 30 minutes after which the precepita-
tion of dye-protein complex may occur. 
4. Estimation of lysine by ninhydrin reagent 
Estimation of free amino groups was accomplished by 
the method described by Moore and Stein (1954). 
a) Preparation of hydrindantin 
Hydrindantin was prepared according to the standard 
procedure (Moore & Stein, 1954) by reducing ninhydrin with 
ascorbic acid. One gm of ninhydrin was dissolved in 25 ml 
of water at 90°C. Five ml of 20% (W/V) ascorbic acid was 
added slowly to ninhdrin solution with constant stirring. 
The reaction was allowed to proceed for 30 minutes, without 
further heating and the contents v;ere cooled under tap 
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water. The hydrindantin crystals, thus formed were filtered 
and dried in a dessicator, under reduced pressure. Dried 
crystals were stored in an amber colour bottle. 
b) Preparation of ninhydrin reagent 
Three hundred mg of ninhydrin and 100 mg of 
hydrindatin were dissolved in 76 ml of methyl cellosolve. 
To this was added 24 ml of 4 M sodium acetate buffer, pH 5.5, 
The contents were mixed thoroughly and filtered through 
Whatman filter paper. The reagent was stored in an amber 
colour bottle at 4°C. 
c) Procedure 
Appropriate dilutions of lysine were placed in test 
tubes and adjusted to a final volume of 1.0 ml. To this was 
added 1.0 ml of 4 M sodium acetate buffer, pH 5.5, followed 
by the addition of 1.0 ml of ninhydrin reagent. The tubes 
were vortexed and incubated in a boiling water bath for 20 
minutes. The tubes were rapidly cooled under tap water and 
finally 5.0 ml of 5% (v/v) double distilled ethanol was 
added. The contents of each tube were thoroughly mixed and 
were monitored at 570 nm. The concentration of lysine in 
the unknown sample v/as determined from the standard plot. 
5. Preparation of antigen for the induction of antibodies 
a) Bromination of DNA 
Purified calf thymus DNA was brominated under high 
salt concentration. For bromination, DNA was dissolved in 
20 mM sodium citrate, pH 7.2, 1 mM EDTA, 4 M NaCl. Aqueous 
bromine reagent was prepared by adding bromine to distilled 
water and mixing thoroughly until the water became saturated 
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with bromine at room temperature. The bromine saturated 
water was added to DNA in the ratio of 1:4. The reaction 
was allowed to proceed at room temperature for 30 minutes. 
Extensive dialysis was done in TNE buffer (15 mM Tris, pH 
7.2, 150 mM NaCl, 1 mM EDTA) to remove excess bromine. The 
bromination of DNA was judged by characteristic UV spectra 
and UV difference spectra. 
b) Preparation of ssDNA 
Single stranded DNA was prepared by dissolving dsDNA 
in PBS (0.01 M Pi buffer, 0.15 M NaCl, pH 7.4) in a 
stoppered test tube and heated in a boiling wat6r bath for 
15 minutes. The tube was fast cooled in ice-sodium chloride 
mixture. The denatured DNA was subjected to hydroxyapatite 
chromatography. 
c) Chromatography of ssDNA on hydoxyapatite column 
A column of hydroxyapatite was prepared in 10 mM 
phosphate buffer, pH 7.2. Heat denatured DNA in 10 mM Pi 
buffer was passed through the column. Fractions of 3.0 ml 
were collected at a flow rate of 30 ml/hr. DNA in each 
fraction was estimated. Fractions eluting at 0.2 M Pi 
buffer were taken as ssDNA (Fig. 2). 
6. Characterization of brominated DNA 
a) Thermal denaturation study of unmodified and modified DNA 
Thermal denaturation analysis of nucleic acid was 
accomplished in order to ascertain the degree of modifica-
tion by determining the mid-point melting temperatures (Tm). 
Brominated DNA (Br-DNA) and its respective control, 
dsDNA in PBS, pH 7.4 were melted at a rate of l°C/min. from 
Figure 2. Chromatography of ssDNA on hydroxyapatite column 
Stepwise elution was carried out using 0.01 M to 
0.3 M phosphate buffer, pH 7.2, as indicated in 
the figure. The DNA concentration in each 
fraction was estimated by diphenylamine reagent. 
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35°C to 95°C. Melting curves were recorded at a fixed 
wavelength of 260 nm. These curves were obtained on 
Shimadzu UV-240 spectrophotometer equipped with a 
temperature programmer and controller (Hasan and Ali, 1990). 
Since Tm is dependent upon the ionic strength of the solvent 
and the nature of the counter ions so a single solvent was 
taken for both Tm determinations. The percent denaturation 
was evaluated by the equation. 
% D = ^obs " ^initial ^ ^ ^Q 
^95°C ~ ^initial 
b) Thermodyncunic analysis of Br-DNA and dsDNA 
The thermal transition of nucleic acid from native 
state to denatured state was characterized as a single 
variable fD, the fraction of the nucleic acid in the 
denatured state. The percent change in absorbance was used 
as experimental variable. Along the transition curve at any 
given point, the observed percent change in absorbance was 
related to the fraction of nucleic acid in the denatured 
state by the following equation: 
f^ _ (^ )obs - (^ N^ 
(A)p - (A)N 
v/here, (A) , , (A)^ si^ d (A)^ represent the percent loss in 
absorbance in any observed, native and fully denatured state 
respectively. 
c) Separation and quantification of bromianted bases 
The identification, separation and quantification of 
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the modified bases was accomplished as described earlier 
(Hasan and Ali, 1990). 
i) Acid hydrolysis of brominated DNA 
Br-DNA solution was precipitated with two volumes of 
cold ethanol. The precipitate was collected after 
centrifugation at 5000 rpm for 10 min and was dissolved in 
70% perchloric acid. The sample was treated in boiling 
\\7ater bath for 1 hr to release the bases. The solution was 
neutralized with NaOH. 
ii) DEAE Sephadex A-50 column chromatography 
The separation of modified bases was performed by 
ion-exchange chromatography on DEAE Sephadex A-50. The gel 
was swelled in distilled water for 1 hr at 90°C. The column 
(30 cm X 2.4 cm) was packed with swelled gel and left 
overnight for gravity packing and equilibrated with 0.02 M 
Tris buffer pH 7.2. Sample (2.5 ml) was loaded and eluled 
with same buffer at a flow rate of 40 ml/hr. One hundred 
and fifty fractions of 2.5 ml were collected and their 
absorbance recorded at 260 nm. The individual modified and 
unmodified bases were identified by their characteristic UV 
spectra. 
d) Detection of Br-DNA by Si nuclease sensitivity 
Brominated DNA was also characterized by Si nuclease 
digestion followed by agarose gel electrophoresis. 
i) Preparation of agarose gel 
The mobility of nucleic acids in agarose gels depend 
upon the concentration of agarose present. Agarose (0.18 gm) 
was dissolved in 30 ml of TAE buffer, pH 8.0 by boiling. 
The solution was allowed to cool at 50°C-60°C and poured 
onto a horizontal tray of GNA-100 electrophoresis apparatus 
(Pharmacia, Sweden). The solution was left at room 
temperature for half an hour for complete solidification. 
The casted gel was 4 mm thick with wells 3 mm deep and 3 mm 
wide. The volume of each well was 9 ul. 
ii) Electrode buffer 
40 mM Tris acetate and 2 mM EDTA, pH 8.0 (TAE buffer). 
ill) Treatment of Br-DNA with Si nuclease 
Two ug each of Br-DNA and native DNA (dsDNA) were 
treated with Si nuclease (20 units/ug nucleic acid) in 
acetate buffer, pH 5 at 37°C. The reaction was stopped by 
the addition of one tenth volume of 0.2 M EDTA, pH 8.0. 
iv) Sample preparation 
The loading buffer concentrate (6X) consist 0.25% 
bromophenol blue, 0.25% xylene cyanol and 15% Ficoll 400 
(Pharmacia) dissolved in water. The treated and untreated 
samples contained one tenth volume of the above solution. 
v) Running condition 
30 volts and 20 mA current for 2 hr. 
vi) Stainning 
The gel was stained with ethidium bromide (1 ug/ml). 
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7. Formation of DNA-MBSA complex 
Br-DNA/ssDNA (0.5 ml) was mixed with equal volume of 
MBSA (v/v). One ml of Freund's complete/incomplete adjuvant 
was mixed. The emulsion was formed at room temperature with 
gentle mixing. 
8. Immunization schedule 
Goat_, (weighing about 30 kg) was injected intra-
muscularly in hind limbs weekly for five weeks with freshly 
prepared Br-DNA-MBSA complex, containing 300 ug of Br-DNA. 
Antisera were separated from the blood obtained through 
jugular vein, 6 to 7 days following the last injection. 
Rabbits (eight to twelve months old weighing 1 to ^cy 
2 kg) were injected intramuscularly for 3 weeks with freshly 
^ JUL 
prepared ssDNA-MBSA complex. Antisera were separated from 
blood obtained by cardiac puncture, seven days after the 
last dose. 
Serum samples were decomplemented by heating at 56°C 
for half an hour and stored in small aliquots at - 20°C with 
0.1% sodium azide as preservative. 
9. Isolation of IgG 
Anti-Br-DNA IgG and preimmune IgG from serum was 
isolated by DEAE Sephacel column chromatography of the crude 
immunoglobin precipitate obtained by 40 percent ammonium 
sulphate saturation of serum. 
a) Preparation of crude IgG 
Four ml of saturated ammonium sulphate solution was 
added dropwise to 6.5 ml of serum with constant stirring in 
cold. The mixture was left at 4°C for 2 hr for complete 
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precipitation. The precipitate was centrifuged at 10,000 rpm 
for 15 minutes and v/ashed thrice with 40% saturated ammonium 
sulphate solution. The washed precipitate was dissolved and 
dialyzed against 0.0175 M phosphate buffer, pH 6.8. 
b) DEAE Sephacel column chromatography 
Crude immunoglobulins were loaded onto a column of DEAE 
Sephacel (28 cm x 1.5 cm) previously equilibrated with 
0.0175 M Pi buffer, pH 6.8. Fractions of 3 ml were eluted 
with the same buffer. Absorbance of each fraction was 
monitored at 280 nm. 
10. Purification of isolated IgG by Sephadex G-lOO column 
chromatography 
Preparative gel filteration chromatography was 
performed on Sephadex G-200 column (30 cm x 2.4 cm). The 
column was packed according to the instructions provided by 
the manufacturers. 
Three ml of IgG sample was loaded onto the packed 
column with the help of an applicator without disturbing the 
surface of the gel. The immunoglobulin G was eluted by 
0.15 M phosphate buffer saline pH 7.4. Fractions of 4 ml 
were collected at a flow rate of 17 ml/hr. The protein 
content of each fraction was monitored at 280 nm. The 
fractions showing single band in SDS-PAGE were pooled and 
used as purified IgG. The pooled IgG was stored at -20°C in 
small aliquots. 
11. Immunoaffinity purification of IgG on Br-DNA-{Poly-L-
Lysyl-Sepharose 4B) column 
Supplied Sepharose 4 B slurry was suspended in 
distilled water and washed with 300 ml of water on a 
sintered glass funnel (porosity G-2). Five gm of moist gel 
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was mixed with 20 ml of 2 M sodium carbonate at 40°C and 
placed on a magnetic stirrer. One gm of CNBr in 0.8 ml 
acetonitrile was added dropwise to the mixture and contents 
were mixed for 15-20 minutes in cold. The mixture was 
filtered through sintered glass funnel and washed with 0.1 M 
sodium bicarbonate (coupling buffer) (Ali, 1984). 
b) Coupling of poly-L-lysine with activated Sepharose 4 B 
Fifty mg of polylysine was dissolved in 5 ml of 0.1 M 
sodium bicarbonate. The solution was added to activated 
Sepharose 4 B and the mixture was incubated overnight at A°C 
with constant slow stirring. The buffer was drained out and 
the gel was packed in a column and washed successively with 
50 ml each of cold (i) distilled water (ii) 0.1 N HCl 
(iii) 0.1 M NaHCO, and (iv) distilled water till neutral. 
The column was equilibrated with 0.15 M acetate buffer, 
pH 4.5. 
c) Affinity purification of antibodies 
Br-DNA (1.5 mg/5ml) in acetate buffer was loaded onto 
a pre-equilibrated column and recycled a couple of times, in 
order to ensure the maximum binding of the Br-DNA to the 
matrix. The flow rate was 15 ml/hr. After loading, the 
column was washed with 50 ml of PBS to eliminate the unbound 
Br-DNA. Crude gammaglobulins from anti-Br-DNA serum which 
has been previously dialyzed against PBS were loaded onto 
the column. After adsorption and recycling a couple of 
times, the unbound material was removed by washing with 40 
ml of PBS. The bound IgG was eluted with a linear gradient 
of NaCl (0.15 M to 3.0 M) in PBS, pH 7.4. Fractions of 3 ml 
were collected at a flow rate of 20 ml/hr. Their absorption 
at 280 nm and 260 nm were recorded. DNA was also estimated 
in peak fractions by diphenylamine reagent. 
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d) Regeneration of the coliimn 
The column was regenerated by washing with 50 ml each 
of cold (i) distilled water (ii) 0.1 N HCl (iii) 0.1 M 
NaHCO^ (iv) distilled water till neutral. 
12. Polyacrylamide gel electrophoris of proteins 
To check the purity of IgG, polyacrylamide slab gel 
electrophoresis was done as described by Laemmli (1970) 
under denaturing conditions. 
a) Solutions and buffers 
i) Acrylamide-bisacrylamide (30:0.8) 
The solution was prepared by dissolving 30 gm of 
acrylamide and 0.8 gm of bisacrylamide in a total volume of 
100 ml. The solution was stored at 4°C in a dark bottle. 
ii) Resolving gel buffer 
36.3 gm of Tris and 48.0 ml of 1 N HCl were mixed and 
brought to 100 ml final volume with water. The solution was 
titrated to pH 8.8 with HCl. 
iii) Stacking gel buffer 
The buffer is made by dissolving 12.1 gm Tris in 
60 ml of 1.25 N HCl, adjusting the pH to 6.8 with 1.25 M HCl 
and bringing to 100 ml final volume with distilled water. 
iv) Reservior buffer 
Trds-glycine buffer (0.025 M Tris and 0.192 M glycine, 
pH 8.3) containing 1% SDS. 
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v) Sample buffer 
Dissolved 6.0 gm of Tris in 80 ml of distilled water 
and adjusted the pH to 6.8 with phosphoric acid. The volume 
was adjusted to 100 ml with distilled water. 
vi) To 12.5 ml of above sample buffer, was added 1 mg of 
bromophenol blue and 12.5 ml of glycerol. This solution is 
refered as 'B'. 
To 1.0 ml of solution 'B' was added 20 mg of SDS. 
This is solution 'C . 
One part of solution 'C and four parts of sample to 
be electrophored were mixed and boiled for two minutes just 
prior to electrophoresis. 
vii) Running conditions 
Samples were electrophorsed at 80 volts at room 
temperature for 8-10 hr. 
viii) Recipe for 7.5% SDS-PAGE 
(For 30 ml total volume) 
Acrylamide-bisacrylamide 7.5 ml 
Resolving gel buffer 3.75 ml 
Distilled water 18.25 ml 
TEMED 15 ul 
Ammonium persulphate 10% 200 ul 
SDS 10% 300 ul 
ix) Recipe of stacking gel buffer 
Acrylamide-bisacrylamide 1.25 ml 
Stacking gel buffer 2.5 ml 
SDS 10% 100 ul 
Ammonium persulphate 1.5% 0.5 ml 
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Distilled water 5.65 ml 
TEMED 7.5 ul 
x) Staining 
The gel was stained with Coomassie Brilliant Blue 
R-250. 
13. Quantitative precipitin titration for the analysis of 
antigen-antibody intraction 
The antigen-antibody intraction was investigated by 
performing precipitin analysis under equilibrium conditions 
in eppendrof microfuge tubes. The antigen antibody reaction 
is a bimolecular reaction hence the lattice formation 
depends upon the concentration of both the components. In 
excess of either of the two, soluble complexes will form. 
Brominated DNA of varying concentration (0-100 ug) were 
allowed to interact with constant amount of anti-Br-DNA 
sera/IgG in the assay tube. The reaction was allowed to 
proceed at room temperature for 2 hr and then overnight at 
4°C. The tubes were microfuged at maximum speed for 4 
minutes. Supernatant was drained off and precipitate was 
washed three times with cold PBS, pH 7.4. Precipitate was 
dissolved in 1 M NaOH. Bound DNA and antibody from the 
dissociated immune complex was determined by diphenylamine 
method and dye binding method. 
14. Gel retardation assay 
A gel electrophoressis assay was used to detect the 
binding of Br-DNA with anti-br-DNA IgG. 
i) Preparation of agarose gel 
Agarose (0.18 gm) was dissolved in 30 ml of TAF buffer 
pH 8.0 by boiling. The solution was allowed to cool a^ , 50°C 
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to 60°C and poured onto a horizontal tray of GNA-100 
electrophoresis apparatus (Pharmacia, Sweden). The solution 
was left at room temperature for half an hour for complete 
solidification. 
ii) Electrode buffer 
40 mM Tris-acetate and 2 mM EDTA, pH 8.0 (TAE Buffer). 
iii) Sample preparation 
Samples were prepared by incubating Br-DNA and anti-
Br-DNA IgG in PBS buffer, pH 7.2 for 2 hours at room 
temperature. 
iv) Sample application 
Samples were loaded into the sample wells with the 
help of a microliter syringe. One tenth volume of 
"stop-mix" was added to ecich sample to increase sample 
density. 
v) Running condition 
Electrophoresis was carried out for three hours at 
40 volts and current of 20 mj\. 
vi) Staining 
Gel was stained with ethidium bromide (1 ug/ml) for 
fifteen minutes and viewed under UV light. 
15- Enzyme linked immunosorbent assay (ELISA) 
The anti-Br-DNA antibodies were detected and 
quantitated by ELISA using polystyrene flat bottom plates as 
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solid phase. The method described by Ali et al (1985) was 
followed. 
i) Tris buffer saline (TBS), pH 7.4 
10 mM Tris, 150 mM NaCl, pH 7.4 containing 0.02% 
sodium azide as preservative. 
ii) Tris buffer saline-Tween-20 (TBS-T) 
20 mM Tris, 144 mM NaCl, 2.68 mM KCl, 500 ul Tween-20 
per liter, pH 7.4. 
ill) Bicarbonate buffer, pH 9.6 
15 mM sodium carbonate, 35 mM sodium bicarbonate and 
2 mM magnisiura chloride, pH 9.6 containing 0.02% sodium 
azide as preservative. 
iv) Substrate 
One ug p-nitrophenyl phosphate per ml in bicarbonate 
buffer, pH 9.6. 
V) Procedure 
DNA (ssDNA or Br-DNA) in TBS buffer, pH 7.4 was 
coated to the wells of nicrotiter flat bottom plates which 
was then incubated for two hours at room temperature and 
then at 4°C overnight. The control and test wells were then 
washed three times with TBS-T and unoccupied sites were 
saturated with 150 ul of 1.5% bovine serum albumin in TBS-T. 
The plates were allowed to stand at room temperature for 
four hours. The plates were then washed two times with 
TBS-T. After washing, serum or IgG was added in both 
control as well as test wells. The plates were again 
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incubated at room temperature for two hours and then 
overnight at 4°C. The plates were again washed three times 
with TBS-T and then anti-goat/rabbit/human IgG alkaline 
phosphatase conjugate was added. The plates were again 
incubated for two hours at room temperature. At the end of 
incubation period the plate was emptied and washed five 
times with TBS-T and finally with distilled water. 
Colourigenic substrate p-nitrophenyl phosphate was added. 
The absorbance of each well was recorded at 410 nm on an 
automatic microplate ELISA reader. The mean absorbance of 
A^ ^ - A . , of duplicates were plotted, test control ^ ^ 
16. Competition ELISA 
The specificity of induced antibodies was checked 
against various nucleic acid polymers by the method 
described by Ali and Ali (1986). Varying concentrations of 
nucleic acid polymers were mixed with anti-Br-DNA IgG. The 
mixture was incubated at 37°C for two hours followed by 
overnight incubation at 4°C, resulted in the formation of 
immune complex. The immune complex thus formed was used in 
ELISA instead of serum. 
17. Chemical modification of amino groups of anti-Br-DNA IgG 
The modification of amino groups of anti-Br-DNA IgG 
with trinitrobenzene sulphonic acid (TNBS) was performed 
according to the method of Haynes et al (1967). The details 
are as follows: 
i) Procedure 
250 ug of anti-Br-DNA IgG in PBS pH 7.4 was mixed 
with 2.5 ml of 4 percent NaHCO-,, pH 8.5, The reaction was 
initiated with 1 ml of one percent aqueous TNBS. The mixture 
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was incubated for various time intervals after which the 
reaction was terminated by the addition of 1.5 ml of 
2 percent lysine. The samples were dialyzed against several 
changes of PBS, pH 7.4. The extent of modification was 
determined by ninhydrin reaction. 
18. Effect of amino group modification on the reactivity of 
anti-Br-DNA IgG 
The reactivity of modified anti-Br-DNA IgG was 
determined by direct binding ELISA. The unmodified anti-Br-
DNA IgG was used as control. 
RESULTS 
Bromination of DNA 
Purified calf thymus DNA was brominated under high 
salt concentration. The bromination of DNA was judged by 
characteristic UV absorption spectra and UV difference spectra 
(Fig. 3). Unmodified DNA was used as control. Brominated 
DNA (Br-DNA)- showed a marked decrease in absorbance at 
260 nm and an increase at 295 nm as compared to native form. 
This is a characteristic feature of Z-DNA. The A„,„-A„QC. 
ratios of native and brominated DNA were found to be 10.5 
and 2.7 respectively (Table 3). 
Thermal Denaturation of Brominated DNA 
Thermal denaturation analysis of nDNA and Br-DNA was 
investigated between 30°C to 95°C. Percent fraction of 
nucleic acids in denatured state at various temperatures and 
Tm can be evaluated by this process. Increase in UV 
absorbance at 260 nm with the increase in temperature was 
taken as a measure of denaturation. Heating of nDNA and 
Br-DNA from 30°C to 80°C did not show any denaturation. 
Completely denatured forms were obtained at 90°c and further 
heating of the sample from 90°C to 95°C did not show any 
significant increase in percent denaturation (Fig. 4). 
The Tm of nDNA was found to be 88°C and that of Br-DNA was 
83°C. The percent hyperchromacity of Br-DNA was found to be 
26.8. The decrease in Tm of Br-DNA indicates the 
destabilization of DNA helix due to bromination. 
Detection of Br-DNA by Time Course Kinetic Analysis 
The process of bromination of DNA was also 
characterized by the measurements of fraction of nucleic 
acid in the denatured state, f„, with time. 
Figure 3. UV absorption and difference spectra of native DNA 
brominated under high salt concentration. Native 
DNA ( - ), Br-DNA ( ). 
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For nDNA, the value of f was very low upto 56 minutes 
of heating at 86°C. However, an abrupt increase in its 
value was observed from 57 to 64 minutes of heating at 87°C 
to 94°C. In the case of Br-DNA upto 52 minutes of heating 
(82°C), very low values of f were obtained. After 
52 minutes an abrupt increase in its value was observed upto 
61 minutes (91°C)/ after which it remains constant upto 
65 minutes (95°C) as shown in Fig. 5. The results reveled 
the formation of single stranded regions due to helix 
destabilization as a consequence of bromination in high 
salt concentration. 
Detection of Br-DNA Formation by Agarose Gel Electrophoresis 
The formation of Br-DNA was checked by agarose gel 
electrophoresis. Samples were treated with Si nuclease and 
subjected to gel electrophoresis. The digested samples 
showed increased mobility which was significantly higher in 
case of Br-DNA (Fig. 6). Further, the Br-DNA band shifted 
its position to the lower side after the treatment of Si 
nuclease. This indicates that single stranded regions are 
generated on DNA after bromination which are digested on 
treatment with single stranded specific enzyme. Si 
nuclease. 
Identification of Modified Bases in Br-DNA 
To separate and identify the modified bases of 
Br-DNA, the polymer was first completely hydrolyzed by 
perchloric acid digestion. The liberated bases were 
separated on a DEAE Sephadex A-50 column. The elution 
profile showed six peaks (Fig. 7) indicating the presence of 
two additional modified bases. The modified and unmodified 
bases were identified by their UV spectra. The 
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Figure 6. Nuclease Si treatment of Br-DNA and nDNA. 
Lanes 1 and 3 contain Br-DNA and nDNA 
respectively. Lane 2 and 4 contain Si treated 
Br-DNA and nDNA. 

Figure 7. Ion exchange chromatography profile of Br-DNA 
hydrolysate on DEAE Sephadex A-50 column. 
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order of elution was modified cytosine, cytosine, thymine, 
adenine, modified guanine and guanine. The unmodified 
cytosine showed a maxima at 265 nm and minima at 242 nm while 
the modified cytosine showed a maxima at 262 nm and a minima 
at 246 nm (Fig. 8). Thymine showed a maxima at 262 nm and a 
minima at 232 nm (Fig. i") . Fourth peak of adenine has a 
maxima at 258 nm and a minima at 224 nm (Fig. 10). Fig, 11 
showed the maxima of modified guanine at 272 nm and 242 nm 
and a minima at 260 nm and 222 nm. The unmodified guanine 
had a maxima at 273 nm and 244 nm and a minima at 260 nm and 
224 nm (Fig. 11). 
The extent of 'modification was determined by 
measuring the peak area of the modified and the 
corresponding unmodified bases. Cytosine and guanine were 
modified to the extent of 20.8% and 39.2% respectively. 
Immunological Characterization of Antibodies Against Br-DNA 
The immunogenecity of anti-Br-DNA antibodies was 
characterized by quantitative precipitin titration, gel 
retardation assay, direct binding ELISA and competition 
ELISA. 
Immunoglobulin G (IgG) were isolated from preimmune 
and immune sera by DEAE Sephacel column chromatography 
(Fig. 12). Isolated IgG was further subjected to Sephadex 
G-lOO column chromatography (Fig. 13). The purity of IgG 
was checked by SDS-PAGE in the absence of reducing agent 
which showed the presence of a single band. Anti-Br-DNA IgG 
were also purified by immunoaffinity chromatography on a 
column of CNBr activated Sepharose 4B-polylysine linked to 
Br-DNA. The coupling efficiency of the affinity column for 
Br-DNA was evaluated by measuring the amount of Br-DNA in 
the wash fractions. About 30 ml of buffer is sufficient to 
remove virtually all the unbound DNA (Fig. 14). Approximately 
Figure 8. UV spectra of unmodified and modified cytosine 
unmodified cytosine (--.--.) and 
modified cytosine (- ) . 
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Figure 11. UV spectra of unmodified and modified guanine, 
unmodified guanine (---) and 
modified auanine (—J . 
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Figure 14. Elution of unbound Br-DNA from affinity column of 
Sepharose 4B-polylysine. The data were used to 
evaluate the binding capacity of the column. 
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91% of Br-DNA was retained on the column (Table 4). The 
bound IgG was eluted from the column with a linear gradient 
of NaCl (0.15 M to 3.0 M) in PBS, pH 7.4. Fractions of 4 ml 
were collected and their absorbance at 280 nm and 260 nm was 
recorded (Fig. 15). 
Quantitative Precipitin Titration 
The antibodies were quantitated by quantitative 
precipitin titration using preimmune serum as control. 
Fig. 16 shows the quantitative binding data of Br-DNA with 
anti-Br-DNA sera. The equivalence zone v\7as flanked by two 
other zones, antibody excess (prozone) and antigen excess 
(postzone) zones. The relationship between the antigen 
added and antigen bound is shown in Fig. 17. As the 
concentration of Br-DNA was increased, the amount of bound 
DNA also increased untill it reaches a maxima. Maximum 
precipitin reaction occured at an effective Br-DNA and IgG 
concentration of 59.1 ug and 24.29 ug respectively. 
Quantitative precipitin titration was also done with Br-DNA 
and anti-Br-DNA IgG. A typical bell shaped curve was 
obtained (Fig. l^). Negligible binding of Br-DNA with 
preimmune IgG was seen. The rejlationship between Br-DNA 
bound and Br-DNA added is shown in Fig. 19. 
Affinity constant for antigen-antibody intraction was 
7 -1 found to be 1.07 x 10 M by Langmuir's plot (Fig. 20). 
Gel Retardation Assay 
The assay was carried out to detect the binding of 
anti-Br-DNA antibodies to Br-DNA. Brominated DNA and 
anti-Br-DNA antibodies were incubated in PBS buffer, pH 7.4 
for 2 hours at room temperature and then analysed by 
electrophoresis on 0.6% agarose gel. The antigen antibody 
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Figure 15. Immunoaffinity purification of induced antibodies 
against Br-DNA on the column of Sepharose 
4B-polylysine-Br-DNA. 
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Figure 16. Quantitative binding data of Br-DNA with 
anti-Br-DNA sera (o-o) and preimmune sera (•-•). 
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Figure 17. Relationship between antigen added and antigen 
bound with immunized (o-o) and preimmunized {•-•) 
sera. 
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Figure 18. Quantitative binding data of Br-DNA with 
anti-Br-DNA IgG (o——-^ and preimmune IgG ( ). 
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Figure 19. Relationship between antigen added and antigen 
bound with immunized (o-o) and preimmunized IgG 
71 
C7^  
X) 
c 
D 
o 
< 
Q 
I 
& 
AO 60 80 
Br -DNA added (ug) 
Figure 20. Langmuir's plot for the determination of affinity 
constant for Br-DNA-anti-Br-DNA antibodies 
intraction-
72 
' / r 
.04 .06 .08 .1 
I / (Ag) unbound 
12 
73 
binding was assessed by the retarded mobility of the Br-DNA 
as a consequence of immune complex formation (Fig. 21). 
Direct Binding and Competition ELISA 
Direct binding ELISA on microtiter plates coated with 
Br-DNA indicated high binding activity with different 
dilutions of immune serum (Fig. 22). The antibody titer was 
found to be 1:51200. Preimmune serum showed no appreciable 
binding to Br-DNA. The isolated immune IgG showed high 
antigen binding as determined by the direct binding ELISA 
(Fig. 23). 
Specificity of purified antibodies was checked by 
competition ELISA using various synthetic polymers as 
inhibitors. When Br-DNA was used as compititor, a maximum 
of 96 per cent inhibition was obtained (Fig. 24 ); fifty 
percent inhibition was seen at an inhibitor concentration of 
5 5 
0.4 ug/ml. Since poly(dG-dm C).poly(dG-dm C) is known to 
exist in Z-conformation, this polymer was also used as 
inhibitor. A maximum of 50 percent inhibition was obtained 
at an inhibitor concentration of 8 ug/ml (Fig. 24 ). 
Cross reactivity of induced antibodies were also 
checked against ssDNA, UV-irradiated DNA and RNA. Percent 
inhibition obtained at different inhibitor concentration is 
shown in Fig. 25 . A maximum of 30, 20 and 15 percent 
inhibition was obtained in the case of ssDNA, nDNA and 
irradiated DNA respectively; no inhibition was obtained with 
RNA. 
To see whether these anti-Br-DNA antibodies bind to 
brominated bases, compitition ELISA was done with brominated 
RNA as inhibitor. A maximum of 41 percent inhibition was 
obtained (Fig. 26 )• A significant inhibition was also 
obtained with poly(dA).poly(dT) and poly(dG).poly(dC) 
(Fig. 26). 
Figure 21. Gel retardation assay of the binding of immune 
IgG with Br-DNA. Lanes 1 and 2 contain Br-DNA 
and lane 3 contain immune complex. 
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Figure 24. Inhibition of anti-Br-DNA antibody binding by 
Br-DNA 5 5 
Br-DNA (o-o) and poly(dG-dm C).poly(dG-dm C) 
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Figure 25. Inhibition of immune IgG binding by various 
nucleic acids. The competitors were dsDNA (Hl>-), 
ssDNA (—O- ) / RNA {-%-' ) , and irradiated DNA 
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Figure 26. Inhibition of anti-Br-DNA antibody binding by 
various DNA polymers. Br-RNA (—0~*^' poly(dA). 
poly(dT) (-C—)/ poly(dG) .poly(dC) { ,m ,. ). 
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Alternate copolymers like poly(dl-dC).poly(dl-dC), 
poly(dA-dU).poly(dA-dU) and poly(rG).poly(dC) were also 
employed as inhibitors and the results are shown in Fig. 27. 
A maximum of 34, 21 and 21 percent inhibition were obtained 
for above polymers respectively. 
The inhibition assay of purified antibodies with 
homopolymers poly(dA),poly(dT) and poly(dC) is shown in 
Fig. 28, All the above homopolymers were found to be poor 
inhibitors of antibody activity. Compitition assay was also 
carried out with poly(dG-dC).poly(dG-dC) in Z conformation 
(brominated in high salt). A maximum inhibition of 65 
percent was obtained at inhibitor concentration of 13 ug/ml 
(Fig. 28). 
Maximum and fifty percent inhibition obtained v/ith 
purified antibodies using various synthetic polymers and 
nucleic acids as inhibitors is shown in Table 5 . 
Effect of Lysine Residue Modification on Antibody Binding 
The lysine residues of anti-Br-DNA IgG were modified 
to varying extent and the reactivity of the resulting 
preparation was assayed by direct binding ELISA. TNBS 
(2,4,6 trinitrobenzene sulphonic acid) which is an specific 
amino group modifying reagent (Ogiso et al, 1974; Ernest and 
Kim, 1974) was used to modify the free amino groups of 
lysine residues of immune IgG. The lysine residues were 
modified for different time periods and the extent of 
modification was estimated by ninhydrin reagent (Fig. 29). 
With the increase in reaction time, the absorbance decreases 
(Fig. 29) showing that more lysine residues are being 
modified. Total number of lysine residues per IgG molecule 
was calculated to be 77. The number of lysine residues 
modified per IgG molecule for different time periods 
increased with time as shown in Fig. 30. The maximum number 
Figure 27. Inhibition of anti-Br-DNA antibody binding by 
poly(rG).poly(dC) (—Q- ), poly(dl-dC) .poly(dl-dC) (-f» 
and poly (dA-dU) .poly (dA-dU) {-^^) . 
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Figure 28. Inhibition of anti-Br-DNA antibody binding by 
nucleic acid polymers. The competitors were 
poly(dC) 4^4, poly dA (—Q- ) / Poly (dT) { ~-Q~ ) , 
Br-poly (dG-dC) . poly (dG-dC) ( - © - ) . 
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Table 5 
Source of Ab Inhibitor 
Br-DNA 
Poly(dG-dm''c). 
poly(dG-dm C) 
Br-Poly(dG-dC). 
poly(dG-dC) 
50% Inhibition Max. 
Inhibition 
0.4 
8.0 
13.0 
96 
50 
65 
nDNA 20 
Anti-Br-DNAIgG ssDNA 
Irradiated DNA 
RNA 
Br-RNA 
Poly(dC) 
Poly(dA) 
Poly(dT) 
Poly{rG).poly{dC) 
Poly(dI-dC)2 
Poly{dA.dU)2 
Poly(dG).poly(dC) 
Poly(dA).poly{dT) 
30 
15 
0 
41 
15 
11 
4 
21 
34 
21 
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of lysine residues modified per IgG molecule was found to be 
63 at 90 minutes. No further increase in modification was 
observed with increase in reaction time. The number of 
lysine residues modified was calculated at constant 
concentration of IgG. Percent modification of lysine 
residues increased with time as shown in Fig. 31. 
The antibody reactivity of IgG modified for varying 
time intervals is depicted in Figures 32 to 34 . A sharp 
decrease in antigen binding was observed. Unmodified IgG of 
the same concentration served as respective control. 
Percent loss in antibody activity of IgG as a result of 
modification for different time periods is shown in Fig. 35. 
Apparent first order rate constant (K) for 
anti-Br-DNA antibodies and TNBS intraction was determined by 
plotting inA cc-At vs. time (Fig. 36), where 
A oc- Percent modification of IgG at time infinity 
At - Percent modification of IgG at time t 
The value of apparent first order rate constant was 
-2 -1 found to be 1.34 x 10 sec 
Recognition of Brominated DNA by SLE Autoantibodies 
Various normal human sera (NHS) and sera of patients 
with SLE were tested for the presence of anti-DNA antibodies 
and anti-Br-DNA antibodies by double immunodiffusion and 
counterimmunoelectrophoresis. No precipitating antibodies 
were detected. These serum samples were tested by direct 
binding ELISA using nDNA and Br-DNA as antigens. Figs. 37 
and 38 shows the reactivity of some SLE sera against Br-DNA 
indicating the presence of high titer antibodies in SLE sera 
against Br-DNA. The reactivity of same SLE sera with native 
DNA is shown in Fig. 39. 
Figure 31. Kinetic analysis of the modification of lysine 
residues of immune IgG with 2, 4, 6 
trinitrobenzene sulphonic acid. 
AO 
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Figure 32. Effect of lysine modification on the binding of 
anti-Br-DNA IgG. 
Unmodified IgG (—0~~) ' modified for zero minutes 
( 0 ), modified for five minutes (—^— ), 
modified for eight minutes ( ^ ). 
25 50 
CONC. OF MODIFIED IgG ug/ml 
Figure 33. Effect of lysine modification on the binding of 
anti-Br-DNA . IgG modified at different time 
intervals. 
Modified for 10 minutes ( '0 • ), 
modified for 20 minutes ( —•^ -^» ) / 
modified for 30 minutes ( -^ - ). 
725 12.5 25 50 
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Figure 34. Effect of lysine modification on the binding of 
anti-Br-DNA IgG modified at different time 
intervals. 
Modified for 45 minutes ( f^ ) , 
modified for 90 minutes (—^)— )/ 
modified for 120 minutes ( — i ^ ). 
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Figure 35. Percent loss in antibody activity of modified IgG 
as a function of time. 
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Figure 36, Determination of apparent first order rate 
constant for anti-Br-DNA antibodies and TNBS 
intraction. 
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Figure 38. Direct binding assay of various SLE sera ( —0~" )' 
( -d-) , {..j^), and NHS { ~tr ) with Br-DNA. 
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Figure 39. Direct binding assay of various SLE sera ( -O" ) ' 
( . ^ ) , ( - 0 ^ ), ( -Q- ) , ( -C- ) "^d NHS 
( itk' ) with nDNA. 
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Since two of the SLE sera (No. 1 and 2) showed high 
antigen binding, the samples were investigated for antigenic 
specificity by compitition ELISA using nDNA and Br-DNA as 
compititors. Percent inhibition obtained at different dsDNA 
concentration is shown in Fig. 40. High degree of 
specificity of antibody against dsDNA was obtained with both 
the sera. A maximum of 75 and 85 percent inhibition was 
achieved with 15 ug/ml of the compititor. Fifty percent 
inhibition of antibody binding was obtained with only about 
6.0 ug/ml and 0.8 ug/ml of DNA. 
Specificity of SLE antibodies were also checked 
against Br-DNA. Percent inhibition obtained at different 
Br-DNA concentration is shown in Fig. 41. A maximum of 63 
and 50 percent inhibition was obtained. The antibody binding 
to ssDNA was much less as 50 percent inhibition in antibody 
activity was achieved with 61 ug/ml of ssDNA (Fig. 42 ). 
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Figure 42. Inhibition of SLE anti-DNA antibody binding by 
ssDNA. The plates were coated with nDNA. 
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DISCUSSION 
The double helical DNA has considerable conformational 
flexibility. It is not a static molecule but rather a 
dynamic structure in which different conformations are in 
equilibrium with each other. The discovery of left-handed 
Z-DNA has added yet another complexity in the conformation 
of native DNA. Z-DNA is a strong immunogen, in contrast to 
B-DNA which is almost nonimmunogenic. 
Bromination of double stranded calf thymus DNA in 
4M NaCl converts some portions of DNA from right handed 
conformation to left handed Z- conformation. Synthetic 
poly(dG-dC).poly(dG-dC) has been shown to attain 
Z-conformation in 4M NaCl and was stabilized in low ionic 
environment of a physiological medium by chemical 
bromination (Moller et al, 1984, Lafer et al, 1981). In 
case of poly(dG-dC), bromine reacted largely with the C-8 
position of guanine and to a lesser extent with the C-5 
position of cytosine (Nordheim et al, 1981; Moller et al, 
1984). The bromine atom at C-8 sterically prevents guanine 
from adopting the anti-conformation (Bugg and Thewalt, 1969; 
Travele and Sobell, 1970). Z-DNA conformation is stabilized 
\7hen approximately, 35% of the guanine residues in the C-8 
position and 17% of the cytosine residues at C5 position are 
brominated (Moller et al, 1984). 
Native DNA brominated in high salt concentration was 
judged by changes in UV absorption spectrum, Tm value and 
reactivity with Si nuclease. As a consequence of 
bromination in high salt nDNA showed altered absorption in 
UV region, similar to that observed with brominated 
poly(dG-dC).poly(dG-dC) (Pohl et al, 1972). The hypo-
chromacity at 260 nra and hyperchromicity at 295 nm with red 
shift is one of the characteristic feature of Z-DNA (Rich et 
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et al, 1984; Latha and Brahmchari, 1986). The absorbance 
ratio for native DNA brominated in high salt was similar to 
the reported value for the Z-form of poly(dG-dC).poly(dG-dC) . 
Thermal denaturation data confirms the above results 
and indicates that Br-DNA is thermodynamically less stable 
than its corresponding unmodifiedpolymer. The thermal 
behaviour of native DNA (nDNA) as control displaying Tm 
value of 88°c is typical of double helical calf thymus nDNA. 
On the contrary, Tm of brominated DNA (Br-DNA) was found to 
be 83°C. The substantial decrease in Tm value was due to 
the fact that helix is destabilized as a result of 
bromination. The results of time dependent denaturation of 
native DNA showed a large lag period prior to its 
denaturation as compared to Br-DNA. This can be ascribed to 
the denaturation of a 'segment' involving the brominated 
sites which consequently initiates the rapid denaturation of 
the Br-DNA. Bromination, disrupts the base pair intraction 
at the bromination sites thereby generating local denatura-
tion consequently resulting in the destablization of the 
helix as compared to native polymer. 
The results of nuclease digestion studies indicate a 
conformational change from B -> Z-form. Nuclease Si is 
known to recognize and cleave some structural feature at the 
junction between its neighbouring right and left handed DNA 
regions (Singletonet et al, 1982). The increased electro-
phoretic mobility of Br-DNA as compared to nDNA after 
nuclease Si treatment, in agarose gel electrophoresis 
indicates the generation of some single stranded portions in 
Br-DNA. The low molecular weight bands indicates that some 
portions of brominated polymer are digested on the treatment 
\/ith Si nuclease. 
The separation of modified bases gives an insightful 
confirmation that the modification incurred as a result of 
bromination of nDNA. Cytosine and guanine were modified to 
102 
the extent of 20.8% and 39.2% respectively. The suggests 
that guanine is a better substrate than cytosine for 
bromination. Our results are close to the aformentioned 
results of brominated poly(dG-dC).poly(dG-dC) in which 
nearly same amount of guanine and cytosine has been 
modified. 
Immunological experiments were carried out which 
demonstrated that Br-DNA was highly immunogenic inducing 
high titer antibodies in goat as analyzed by direct binding 
ELISA. Similar observations were obtained with brominated 
poly(dG-dC).poly(dG-dC) which proved to be a potent 
immunogen inducing about 1.2 mg of antibodies per milliliter 
of serum (Lafer et al, 1981). To isolate the immunogen 
specific anti-Br-DNA antibodies from total IgG populations, 
the sample was passed through immunoaffinity column. 
Conventional ligand of nucleic acid with CNBr activated 
Sepharose 4B has been avoided due to a number of inherent 
limitations. Instead, the antigen was linked noncovalently 
to Sepharose 4B-polylysine. 
Efficient binding of Br-DNA to the matrix was noted 
and the IgG eluted from the affinity column showed 
appreciable binding to the immunogen. The formation of 
immune complex was detected by gel retardation assay. The 
retarded mobility of Br-DNA and anti-Br-DNA antibodies was 
the result of formation of immune complex whereas no 
retardation was seen in case of antigen alone or with 
preimmune antibody. This indicates that antibodies were 
generated against Br-DNA. 
The modified polymer was highly immunogenic inducing 
high titer antibodies in goat as analyzed by direct binding 
ELISA. The specificity of polyclonal, electrophoretically 
pure anti-Br-DNA IgG was ascertained by compitition ELISA 
using a variety of DNA polymers. Maximum inhibition (96%) 
was achieved by the immunogen. The remarkable recognition 
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of anti-Br-DNA antibodies by Br-DNA reveals the highly 
specific character of the induced antibodies. The presence 
of conformational specific antibodies in the polyclonal 
immune sera was evident from the appreciable inhibition in 
5 5 
the antibody activity by poly(dG-dm C).poly(dG-dm C), which 
is known to exist in the Z-form in solutions under physio-
logical conditions. Thus, the recognition of this conformer 
by anti-Br-DNA antibodies is suggestive for the presence of 
antibodies against Z-like conformation in the immune sera. 
Moreover, the low binding v/ith single stranded DNA and UV 
irradiated DNA speculated for the presence of a very small 
population of antibodies directed against these nucleic acid 
variant. The binding of ssDNA may be attributed due to the 
generation of single stranded portions (3-4 base pair) at 
the B-Z-junctions, thereby giving rise to single stranded 
determinants which may consequently be responsible for the 
generation of anti-single stranded populations of 
antibodies. The non-inhibitory nature of the antibodies vvith 
nDNA suggests that the antigenic determinants does not lie 
on the sugar phosphate backbone of the nucleic acid. 
Hov/ever, forty percent inhibition in the antibody 
activity by Br-RNA speculates for the possible involvement 
of the modified bases which may act as a potential epitopes, 
responsible for the induction of a small population of 
antibodies directed against them. Poor inhibition was 
obtained with poly(dA),poly(dT) and poly(dC) again shows the 
non-reactivity of antibodies with unmodified bases. 
Appreciable inhibition of antibody binding to Br-DNA 
was obtained with poly(dG).poly(dC) and poly(dA).poly(dT). 
The possibility for the involvement of sugar phosphate 
backbone in antigenicity has already been ruled out as 
evident from bhe above results. Thus the appreciable 
inhibition in the antibody activity with these polymers 
might be due to recognition of the nev/ conformation provided 
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by the polymers, since polypurines in one strand and 
polypyrimidines in the other strand posses neither A-type 
nor B-type conformation. They provide a unique conformation 
which is in between the A and B-type. Thus, it seems that 
this new conformation may some how be closely related or 
resemble the Z-type of conformation provided by Br-DNA. 
These antibodies does not react with poly(rG).poly(dC) which 
is known to exist in A-form. 
Anti-Br-DNA antibodies showed binding with Z-form of 
poly(dG-dC).poly(dG-dC). Quantitative precipitin titration 
data further substantiates the above results. The induced 
antibodies are thus conformational specific, reacting only 
with the modified conformation of nDNA. 
The importance of reactive groups in the side chains 
of immunoglobulins in maintaining the native conformation 
and immuno-chemical reactivity has been and is a broad 
subject of study (Yasushi et al, 1972). Chemical 
modification of proteins by virtue of covalent introduction 
of new groups (without rupture of primary chemical bonds) 
may modify the intramolecular forces, so as • to cause 
"reorganization of the molecular conformation". The 
magnitude of this reorganization depends on the 
characteristics of the groups introduced. This confor-
mational reorganization through its effects on the protein 
molecule may be similar to denaturation. The biological 
role of lysine residues in several enzymes has been 
demonstrated by chemical modification techniques. The 
disrupting influence of lysine modification depends on the 
folded stability and on how necessary the lysine residues 
are for the formation of ordered structures. Lysine 
residues of anti-Br-DNA immune IgG were modified by 
trinitrophenylation. The results of the present study 
demonstrate that by increasing the time of modification of 
lysine residues anti-Br-DNA IgG lost its binding to the 
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immunogen. The extent of reaction of TNBS with anti-Br-DNA 
antibodies suggests that most of the lysyl residues are 
either on the surface of the IgG molecule or accessible to 
the modifier. 
The inhibition of IgG binding to Br-DNA to the extent 
of 90% with only 50% modification of lysine residues 
suggests that these residues are equally involved in antigen 
binding. Anti-Br-DNA IgG contains 77 lysine residues and to 
pin-point the involvement of specific lysine residue(s) in 
antigen binding has not been investigated. 
In the present study, various normal human sera and 
sera of patients with SLE were checked for the presence of 
anti-DNA antibodies and anti-Br-DNA antibodies. Auto-
antibodies play a pathogenic role in variety of clinical 
conditions. While the direct or indirect pathogenic role of 
autoantibodies has been well established in conditions such 
as autoimmune hemolytic anemia, systemic lupus erythema-
tosus, rheumatoid arthritis, myasthenia gravis etc. their 
precise significance in many of the diseases in which they 
are detected remains the object of controversy (Melissa V. 
et al, 1989). Systemic lupus erythematosus (SLE) is a 
prototype autoimmune disease characterized by the formation 
of a variety of autoantibodies and hypergammaglobulinemia 
(Tsutomus T. 1985). Anti-double stranded DNA (anti-ds DNA) 
is generally recognized as the most sensitive and specific 
autoantibodies in SLE (John B.H. and R.H. Scofield, 1991). 
By competition ELISA, anti-DNA autoantibodies were 
found to be specific for native double stranded DNA with 
poor reactivity with single stranded polymer. Our results 
are in full agreement with previous findings that some 
antibodies react exclusively with denatured DNA, where as 
others recognize both native and denatured forms and a 
smaller but important population prefer native over 
denatured DNA. 
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The SLE anti-DNA antibodies showed appreciable 
binding with Z-conformation of calt thyraus DNA brorninated 
under high salt as evident from the results of direct 
binding assay and competition assay. Sera from SLE and 
other autoimmune diseases have been found to contain 
antibodies against Z-conformation of poly(dG-dm C). 
poly(dG-dm C) and brorninated poly(dG-dC).poly(dG-dC) (Sibley 
et al, 1984); Lafer et al, 1983). 
In conclusion, these studies point out the existance 
of regions in native DNA capable of transition from B -> Z 
conformation under adverse conditions. Since Z-DNA is 
highly immunogenic, the antibodies induced against Br-DNA 
appears to be highly specific for the modified polymer 
probably recognizing the changed conformation of the 
modified polymer. The altered polymer showed appreciable 
binding with human anti-DNA autoantibodies. The possibility 
of an altered polymer acting as antigen for the production 
of human autoantibodies could be one of the factors for the 
pathogenasis of SLE. 
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